Citations

Clear

4610 citation(s) found for "Lu, Brian".

Clinical Worsening in Reversible Cerebral Vasoconstriction Syndrome
Katz, Brian, Fugate, Jennifer E. , Lereis, Virginia Pujol , Mandrekar, Jay , Flemming, Kelly D. , Kallmes, David F. , Katz, Brian S, Ameriso, Sebastian Francisco , Rabinstein, Alejandro A. , Flemming, Kelly D

Mayo Clinic

JAMA Neurology | November 4, 2013 | Volume: 71 | Issue: 1 | Pages: 68

10.1001/jamaneurol.2013.4639 | PMID 24190097 Get It

The impact of perioperative blood transfusion on survival after nephrectomy for non‐metastatic renal cell carcinoma ( RCC )
Linder, Brian J. , Thompson, R. Houston, Leibovich, Bradley C. , Cheville, John C. , Lohse, Christine M. , Gastineau, Dennis A. , Boorjian, Stephen A. , Linder, Brian J

Mayo Clinic

BJU International | October 29, 2013 | Volume: 114 | Issue: 3 | Pages: 368-374

10.1111/bju.12535 | PMID 24471825 Get It

Objective To evaluate the association of perioperative blood transfusion ( PBT ) with survival after nephrectomy. Patients and Methods We identified 2318 patients who underwent partial or radical nephrectomy at M ayo C linic between 1990 and 2006. PBT was defined as transfusion of allogenic red blood cells during surgery or postoperative hospitalisation. Survival was estimated using the K aplan– M eier method and compared with the log‐rank test. Cox proportional hazards regression models were used to evaluate the association of PBT with outcome. Results In all, 498 patients (21%) received a PBT . The median (interquartile range) number of units transfused was 3 (2, 5). Patients receiving a PBT were significantly older at surgery ( P < 0.001), more likely to be female ( P < 0.001), with more frequent symptomatic presentation ( P < 0.001), worse E astern C ooperative O ncology G roup performance status ( P < 0.001), and more frequent adverse pathological features, such as high nuclear grade ( P < 0.001), locally‐advanced tumour stage ( P < 0.001) and lymph node invasion ( P < 0.001). The median follow‐up was 9.1 years. Receipt of a PBT was associated with adverse 5‐year cancer‐specific (68% vs 92%; P < 0.001) and overall (56% vs 82%; P < 0.001) survival. On multivariate analyses, PBT remained associated with higher risk of death from any cause (hazard ratio [ HR ] 1.23; P = 0.02). Among patients who received a PBT , an increasing number of units transfused was independently associated with increased all‐cause mortality ( HR 1.08; P = 0.001). Conclusion PBT is associated with a significantly increased risk of mortality after nephrectomy. While external validation is needed, continued efforts to minimise the use of blood products in these patients are warranted.
Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma
Marri, Preethi, Hodge, Lucy S. , Maurer, Matthew J. , Ziesmer, Steven C., Link, Brian K. , Cerhan, James R. , Novak, Anne J. , Ansell, Stephen M. , Marri, Preethi Reddy, Slager, Susan L. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Link, Brian K

Mayo Clinic

Clinical Cancer Research | October 19, 2013 | Volume: 19 | Issue: 24 | Pages: 6812-6819

10.1158/1078-0432.ccr-13-1879 | PMID 24141626 Get It

Abstract Purpose: Although the International Prognostic Score (IPS) is the gold standard for risk-stratifying patients with classical Hodgkin lymphoma (cHL), these criteria do not accurately predict outcome. As cytokines are critically involved in driving cHL, we tested whether pretreatment serum cytokine levels could provide additional prognostic information. Experimental Design: Thirty cytokines were measured in pretreatment serum from 140 patients with cHL and compared with 50 nonlymphoma controls. Patients were followed for event-free survival (EFS) and overall survival (OS), and Cox proportional hazards regression models were used to assess the association of individual cytokines and the cytokine profiles with outcome via unadjusted and IPS-adjusted HR. Results: Twelve cytokines (EGF, bFGF, G-CSF, HGF, IL-6, IL-8, IL-12, IL-2R, IP-10, MIG, TNF-α, and VEGF) were significantly (P &lt; 0.05) higher in patients with cHL than controls; elevated levels of HGF, IL-6, IL-2R, IP-10, and MIG were all associated with poorer EFS. Only interleukin-2 receptor (IL-2R; P = 0.002) and interleukin (IL)-6 (P &lt; 0.001) were independently prognostic. Patients with increased IL-6 and IL-2R had a significantly higher risk of early relapse and death, a finding that remained significant even after IPS-based risk stratification. Although elevated IL-6 and IL-2R correlated with the IPS, soluble CD30 (sCD30), and thymus and activation-related chemokine (TARC) levels, the two-cytokine model remained independently predictive of prognosis. Conclusions: Elevated pretreatment serum cytokines are associated with increased disease relapse and inferior survival in cHL. Thus, the pretreatment cytokine profile, particularly serum levels of IL-6 and IL-2R, may be used to identify patients with cHL at high risk for early-disease relapse. Clin Cancer Res; 19(24); 6812–9. ©2013 AACR.
Simultaneous PML-IRIS and myelitis in a patient with neuromyelitis optica spectrum disorder
Flanagan, Eoin P. , Aksamit, Allen J. , Kumar, Neeraj , Morparia, Neha, Morparia, Neha P, Weinshenker, Brian G. , Keegan, B. Mark , Flanagan, E P

Mayo Clinic

Neurology Clinical Practice | October 14, 2013 | Volume: 3 | Issue: 5 | Pages: 448-451

10.1212/cpj.0b013e3182a78f82 | PMID 29473607 Get It

The outcome of patients with oesophageal eosinophilic infiltration after an eight‐week trial of a proton pump inhibitor
Vázquez‐Elizondo, Genaro , Ngamruengphong, Saowonee, Khrisna, Matthew Brian , DeVault, Kenneth R. , Achem, S. R., Talley, Nicholas J.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | October 12, 2013 | Volume: 38 | Issue: 10 | Pages: 1312-1319

10.1111/apt.12513 | PMID 24117619 Get It

SummaryBackgroundCurrent diagnostic guidelines recommend that eosinophilic oesophagitis (EoE) should be diagnosed only after GERD is excluded by a lack of response to a trial of acid suppression. There is limited information available providing outcome data about the effectiveness of this approach.AimTo examine the impact of double‐dose proton pump inhibitor (PPI) therapy on symptoms, endoscopic and histological features in patients with documented oesophageal eosinophilia consistent with EoE (≥15 eosinophils/high‐power field).MethodsSixty consecutive symptomatic patients with documented oesophageal eosinophilia received open‐label omeprazole 20 mg orally twice daily before meals for 8 weeks. Clinical, endoscopic and histological (resolution: 0–5 eosinophils/HPF, partial improvement: 5–14 eosinophils/HPF), or no improvement: (≥15 eosinophils/HPF) evaluation was repeated at the end of this period. An expert GI pathologist, unaware of the study aims, reviewed all slides.ResultsClinical improvement occurred in 43 (71.6%), endoscopic signs were reduced in 34 (61.8%) and normalised in 12 (21.8%), and histologically, 34 (56.6%) improved, while 15 (25%) obtained complete resolution. Overall, 22 patients (36.7%) obtained both complete clinical and histological remission.ConclusionsMore than 50% of patients with documented oesophageal eosinophilic infiltration in the EoE range improved when treated with a double‐dose PPI trial for 8 weeks. These findings support the published guidelines recommending a PPI trial prior to diagnosing EoE, and confirm the existence of an eosinophilic oesophageal infiltrationPPI‐responsive population.
Similarity of geleophysic dysplasia and weill–marchesani syndrome
Kochhar, Aaina , Kirmani, Salman , Cetta, Frank , Younge, Brian R., Hyland, James, Michels, Virginia V.

Mayo Clinic

American Journal of Medical Genetics Part A | October 12, 2013 | Volume: 161 | Issue: 12 | Pages: 3130-3132

10.1002/ajmg.a.36147 | PMID 24214363 Get It

The acromelic dysplasias comprise short stature, hands and feet, and stiff joints. Three disorders are ascribed to this group, namely Weill–Marchesani syndrome, geleophysic dysplasia, and acromicric dysplasia, although similar in phenotype, can be distinguished clinically. Weill–Marchesani syndrome, on the basis of microspherophakia and ectopia lentis; geleophysic dysplasia by progressive cardiac valvular thickening, tracheal stenosis, and/or bronchopulmonary insufficiency, often leading to early death. Microspherophakia has not been reported previously in geleophysic dysplasia. Mutations in FBN1, ADAMTS10, or ADAMTS17 cause Weill–Marchesani syndrome by disrupting the microfibrillar environment, while geleophysic dysplasia is associated with enhanced TGF‐β signaling mediated through mutations in FBN1 or ADAMTSL2. We studied a 35‐year‐old woman with geleophysic dysplasia, with short stature, small hands and feet, limitation of joint mobility, mild skin thickening, cardiac valvular disease, restrictive pulmonary disease, and microspherophakia. Sequencing of ADAMTSL2 demonstrated two changes: IVS8‐2A>G consistent with a disease‐causing mutation, and IVS14‐7G>A with potential to generate a new splice acceptor site and result in aberrant mRNA processing. The unaffected mother carries only the IVS8‐2A>G transition providing evidence that the two changes are in trans‐configuration in our patient. © 2013 Wiley Periodicals, Inc.
Are Meningeal Hemangiopericytoma and Mesenchymal Chondrosarcoma the Same?
Fritchie, Karen , Jin, Long , Ruano, Ana Belén García , Oliveira, André M. , Fritchie, Karen J. , Rubin, Brian P.

Mayo Clinic

American Journal of Clinical Pathology | October 11, 2013 | Volume: 140 | Issue: 5 | Pages: 670-674

10.1309/ajcpgungp52zsdns | PMID 24124145 Get It

P3–217: Effect of intellectual lifestyle and Alzheimer's disease biomarkers on rate of cognitive decline: Mayo Clinic Study of Aging
Lesnick, Timothy G. , Przybelski, Scott A. , Lowe, Val J. , Roberts, Rosebud O., Gregg, Brian E., Gunter, Jeffrey L. , Petersen, Ronald C. , Vemuri, Prashanthi , Knopman, David S. , Machulda, Mary M. , Mielke, Michelle M. , Geda, Yonas E. , Senjem, Matthew L. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2013.05.1290 Get It